Full-length hippocalcin also bound preferentially to liposomes supplemented with PtdIns(4,5)P 2 . Co-expression of hippocalcin-(1-14)-ECFP (enhanced cyan fluorescent protein) or NCS-1-ECFP partially displaced the expressed PH (pleckstrin homology) domain of phospholipase δ1 from the plasma membrane in live cells, indicating that they have a higher affinity for PtdIns(4,5)P 2 than does this PH domain. The Golgi localization of the PH domain of FAPP1 (four-phosphate-adaptor protein 1), which binds to phosphatidylinositol 4-phosphate, was unaffected. The localization of NCS-1 and hippocalcin is likely to be determined, therefore, by their interaction with PtdIns(4,5)P 2 .
Full-length hippocalcin also bound preferentially to liposomes supplemented with PtdIns(4,5)P 2 . Co-expression of hippocalcin-(1-14)-ECFP (enhanced cyan fluorescent protein) or NCS-1-ECFP partially displaced the expressed PH (pleckstrin homology) domain of phospholipase δ1 from the plasma membrane in live cells, indicating that they have a higher affinity for PtdIns(4,5)P 2 than does this PH domain. The Golgi localization of the PH domain of FAPP1 (four-phosphate-adaptor protein 1), which binds to phosphatidylinositol 4-phosphate, was unaffected. The localization of NCS-1 and hippocalcin is likely to be determined, therefore, by their interaction with PtdIns(4,5)P 2 .
INTRODUCTION
Many cellular proteins are targeted to intracellular membranes following post-translational addition of fatty acyl moieties such as palmitate or myristate [1] [2] [3] , with the latter occurring co-translationally. These additions allow interaction with lipid bilayers, but proteins need additional targeting information to allow them to reach the appropriate intracellular location, and indeed myristoylated and palmitoylated proteins can have diverse localizations within cells [2, 3] . The NCS (neuronal calcium sensor) family of proteins are a series of Ca 2+ -binding proteins, many of which are expressed only in neuronal cell types [4, 5] . One member of the family, NCS-1, has more widespread expression in mammalian tissues, and orthologues of NCS-1 are present in all species from yeast [6] to humans. Many of the NCS proteins are N-terminally myristoylated, and the study of recoverin, the first NCS protein to be discovered, led to the concept of the Ca 2+ /myristoyl switch [7] [8] [9] . Structural and biochemical studies established that the myristoyl group on recoverin is sequestered into a hydrophobic pocket in the Ca 2+ -free form, and that Ca 2+ binding leads to a substantial conformational change that flips out the myristoyl group and allows recoverin to become reversibly membraneassociated. The existence of such a myristoyl switch has been confirmed in living cells for other NCS proteins, including hippocalcin [10, 11] , neurocalcin δ [12] , VILIP-1 (visinin-like protein 1) [13,13a] and VILIP-3 [14] . NCS-1, in contrast, is membraneassociated in a myristoyl-dependent manner even at low Ca 2+ concentrations, suggesting [11, 15] that its myristoyl group is constitutively exposed [16, 17] .
Hippocalcin translocates in response to an elevation of the intracellular Ca 2+ concentration to the same membrane localizations where NCS-1 is found when the two proteins are expressed in the same cell [11] . These appear to be the plasma membrane and the Golgi complex (particularly the trans-Golgi network) [11, [18] [19] [20] . Neurocalcin δ, VILIP-1 and VILIP-2 also translocate to the plasma membrane and Golgi complex in response to Ca 2+ elevation [12] [13] [14] . In contrast, KChIP1 (K + channel-interacting protein 1), another NCS protein that is also constitutively membrane-associated through its myristoylation, is targeted to distinct vesicular structures, and this targeting is important for its ability to stimulate the traffic of Kv4 potassium channels to the cell surface [21] . Interestingly, the distinct targeting of hippocalcin/NCS-1 compared with KChIP1 can be reproduced by attaching the minimal N-terminal myristoylation sequences (of 11-14 residues) to GFP (green fluorescent protein), showing that these N-terminal sequences contain targeting information in addition to the residues required for recognition by N-myristoyltransferase [22] . In contrast, N-terminal myristoyl sequences from certain other proteins are not even sufficient for membrane association [23] . Within the hippocalcin/NCS-1 sequences, three basic residues at positions 3, 7 and 9 are crucial for targeting to the plasma membrane and Golgi complex [21] .
Abbreviations used: CES liposomes, liposomes consisting of a mixture of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine; ECFP/EGFP/EYFP, enhanced cyan/green/yellow fluorescent protein; FAPP1, four-phosphate-adaptor protein 1; GFP, green fluorescent protein; KChIP1, K + channel-interacting protein 1; MARCKS, myristoylated alanine-rich C-kinase substrate; myr-hip-(2-14), biotinylated, myristoylated hippocalcin-(2-14) peptide; NCS, neuronal calcium sensor; PH, pleckstrin homology; PLC, phospholipase C; VILIP, visinin-like protein. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email burgoyne@liv.ac.uk).
Consistent with these findings, structural studies on another NCS protein, recoverin, bound to a phospholipid bilayer revealed that its N-terminal basic residues are in close contact with the phospholipid head groups [24] . This led us to investigate the molecular basis of the targeting of the NCS myristoylation motifs, and whether this could be determined by specific lipid interactions. Our findings demonstrate that the N-terminal motif of hippocalcin and NCS-1 specifically binds PtdIns(4,5)P 2 with high affinity both in vitro and in living cells.
MATERIALS AND METHODS

Reagents
The plasmids for hippocalcin-( 
Binding of biotinylated peptides to immobilized lipids
PIP strips TM (Echelon, Salt Lake City, UT, U.S.A.) were blocked for 1 h at room temperature in blocking buffer [10 mM Tris/HCl, pH 8.0, 150 mM NaCl, 2 % (w/v) fatty acid-free BSA, 0.5 mM MgCl 2 , 0.05% (v/v) Tween-20]. Membranes were subsequently incubated with peptides at 100 ng/ml in blocking buffer for 1 h at room temperature, followed by six 5 min washes in blocking buffer and subsequent incubation with streptavidin-horseradish peroxidase (1:500; Amersham Biosciences) in blocking buffer for 1 h at room temperature. Membranes were washed six times with blocking buffer, and peptide binding was detected with ECLPlus ® reagents (Amersham Biosciences).
Liposome binding assays
Lipids were added to dry, chloroform-washed borosilicate vials with Teflon TM -coated caps (Fisher Scientific). The standard liposome composition consisted of 1.2 mg of phosphatidylcholine (Instruchemie, Delfzijl, The Netherlands), 1.2 mg of phosphatidylethanolamine (Instruchemie), 0.3 mg of phosphatidylserine (Instruchemie), and 0.3 mg of test lipid. The additional lipids used were phosphatidylinositol (Instruchemie), PtdIns4P (Instruchemie), PtdIns(4,5)P 2 (Instruchemie), PtdIns3P (Sigma, Poole, Dorset, U.K.), PtdIns(3,5)P 2 (Sigma), PtdIns(3,4,5)P 3 (Sigma) and phosphatidic acid (Sigma). Lipid mixtures were dried under a stream of N 2 and placed in a desiccator for 10 min, resuspended in 1.5 ml of liposome buffer (50 mM Hepes, pH 7.4, 100 mM NaCl, 0.5 mM EDTA) and sonicated for 1 min at 20 % amplitude using a GEX-600 sonicator fitted with a micro-tip probe (Ultrasonic Processor). Samples were split into 500 µl aliquots and liposomes were pelleted by centrifugation at 500 g for 10 min. Supernatants were discarded and liposomes resuspended in liposome buffer supplemented with peptide. Binding reactions were allowed to proceed for 90 min at room temperature, after which liposomes were collected by centrifugation, washed in liposome buffer and re-isolated by centrifugation. Supernatants were discarded and final pellets were resuspended in 20 µl of liposome buffer. Then 5 µl of each sample was spotted on to nitrocellulose filters and incubated in Ponceau-S (Sigma) for 5 min at room temperature, followed by washing to reveal bound peptide, which was quantified by densitometry. The [
35 S]methionine-labelled fulllength hippocalcin was prepared using a TNT ® quick coupled transcription/translation system (Promega) according to the manufacturer's protocol and with plasmid encoding hippocalcin as template. Synthesized hippocalcin was visualized by autoradiography. After incubation with liposomes and washing, bound hippocalcin was quantified using scintillation counting.
Confocal laser scanning microscopy
For confocal laser scanning microscopy, live or fixed transfected cells were analysed using a Leica TCS-SP-MP microscope (Leica Microsystems, Heidelberg, Germany) with a 22 µm pin hole and a 63× water-immersion objective with a 1.2 numerical aperture. For optimal imaging of ECFP, cells were excited at 405 nm and light was collected at 450-500 nm. FITC was imaged using excitation at 488 nm and light collection at 500-560 nm. For optimal imaging of EGFP, cells were excited at 488 nm and light was collected at 500-550 nm. For imaging of EYFP, the cells were excited at 514 nm and light was collected at 545-625 nm. For optimal imaging of Texas Red, cells were excited at 543 nm and light was collected at 600-650 nm. Images were exported as TIFF files and compiled in CorelDraw. In some cases, fluorescence was quantified by drawing regions of interest around the outside and the inside of the plasma membrane to allow determination of the percentage of total fluorescence close to the plasma membrane.
RESULTS
Targeting of N-terminal myristoylation motifs of hippocalcin, and localization of hippocalcin synthetic N-terminal peptides
The N-terminal 14 residues of the myristoylation motif of hippocalcin are sufficient to target EGFP to the same structures (plasma membrane and Golgi) as full-length NCS-1 ( Figure 1 ). In contrast, the myristoylation motif of the related NCS protein KChIP1 led to targeting to distinct cellular structures (Figure 1 ). These are the same structures to which full-length KChIP1 is targeted [21] . We wondered whether the molecular basis for the distinct targeting of the myristoylated proteins could be examined using synthetic peptides as probes. Three peptides were synthesized, representing the N-terminal sequences of myristoylated hippocalcin, nonmyristoylated hippocalcin or myristoylated KChIP1, each with biotin added to a C-terminal lysine residue (Figure 2A) . In order to determine whether these synthetic peptides could reproduce the localization of the GFP fusion proteins, they were introduced into digitonin-permeabilized HeLa cells following transfection with NCS-1-ECFP, hippocalcin-(1-14)-EGFP or KChIP1-ECFP and their localization was detected by incubation with streptavidin-Texas Red. The digitonin-permeabilization procedure caused the cells to round up, but it was clear that myr-hip- (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) [biotinylated, myristoylated hippocalcin-(2-14) peptide] became cell associated and localized to the same structures that were labelled by NCS-1-ECFP or hippocalcin-(1-14)-EGFP ( Figure 2B , panels i and ii). In contrast, the nonmyristoylated peptide did not become stably cell associated ( Figure 2B, iii) . The localization of the myr-KChIP1-(2-13) peptide was examined in cells transfected to express full-length KChIP1-ECFP, but this peptide also did not become cellassociated ( Figure 2B, iv) . These data suggest that the myr-hip-(2-14) peptide can specifically replicate the targeting of NCS-1 or the N-terminal sequence of hippocalcin. For reasons that are unclear, the KChIP1 peptide, unlike the sequence fused to EYFP, could not bind to cellular structures with high enough affinity. Overall, both myristoylation and N-terminally encoded targeting information within hippocalcin are required and sufficient for subcellular localization.
Binding of synthetic N-terminal peptides to lipids
Within the N-terminal myristoylation sequence of NCS-1 and hippocalcin, basic amino acids in close proximity to the myristoylation site are conserved in the two proteins, and determine their targeting to the Golgi and plasma membrane [21] . KChIP1 lacks the identified crucial basic amino acids at positions 3, 7 and 9 [21] . We wondered if these basic residues might mediate targeting by binding to specific acidic phospholipids unique to distinct organelles, such as PtdIns4P at the trans-Golgi network or PtdIns(4,5)P 2 at the plasma membrane. In these studies we used the synthetic peptides as probes. To initially examine the potential lipid-binding characteristics of the N-terminal targeting residues, we analysed the binding of both the myristoylated and non-myristoylated peptides to a series of immobilized lipids (Figure 3) . The myr-hip-(2-14) peptide exhibited an apparently wide spectrum of lipid-binding activity, but binding was higher for phosphorylated lipids. Binding did not occur to all acidic phos- pholipids, as no binding was detectable to sphingosine 1-phosphate or phosphatidylserine. The control non-myristoylated peptide did not bind any of the lipids, and nor was any binding observed with the myristoylated peptide derived from KChIP1. These data suggest that the N-terminal hippocalcin peptide could interact specifically with particular phospholipids in a myristoylation-dependent manner.
Binding of proteins to immobilized lipids does not always reproduce the correct degree of lipid specificity. Therefore we also examined the association of the myr-hip-(2-14) peptide with synthetic liposomes, a system more closely resembling membrane topology in vivo ( Figure 4A ). The standard liposome composition consisted of a mixture of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine (CES liposomes), which was supplemented with various phosphoinositides. Consistent with the assay on immobilized lipids, little binding was detected to CES liposomes. The greatest level of peptide binding in these experiments ( Figure 4B ) was observed to liposomes supplemented with PtdIns(4,5)P 2 . To delineate the likely physiological relevance of such a peptide-lipid interaction, we determined the binding affinity of myr-hip-(1-14) peptide for control (CES) liposomes or liposomes supplemented with PtdIns, PtdIns4P or PtdIns(4,5)P 2 ( Figure 4C ). The interaction with PtdIns(4,5)P 2 was of the highest affinity, with a K d of ≈ 50 nM, an affinity higher than reported for isolated PH domains where binding to PtdIns(4,5)P 2 has been well characterized [27] .
Binding of radiolabelled full-length hippocalcin to liposomes
In order to confirm this specific preference for PtdIns(4,5)P 2 , and that this was not just a feature of the synthetic peptide, binding of full-length hippocalcin was assayed to liposomes supplemented with PtdIns, PtdIns4P or PtdIns(4,5)P 2 . In order to do this in a quantitative manner and with myristoylated protein, radiolabelled hippocalcin was generated using in vitro transcription and translation ( Figure 5A ). This system has been shown to allow myristoylation of the newly synthesized proteins [28] . The [
35 S]methionine-labelled hippocalcin became bound to liposomes after incubation in the presence of 1 µM free Ca 2+ , and again did so with a preference for liposomes supplemented with PtdIns(4,5)P 2 ( Figure 5B ). Full-length hippocalcin has its myristoyl group sequestered in the Ca 2+ -free state, and this is exposed on Ca 2+ binding. Hippocalcin would be expected, therefore, to show a completely Ca 2+ -dependent interaction with liposomes if the binding is physiologically relevant. The specificity of binding to PtdIns(4,5)P 2 -supplemented liposomes was shown by the finding that this was indeed Ca 2+ -dependent as predicted; in the absence of Ca 2+ , binding was at the same level as to CES liposomes ( Figure 5C ).
Interaction of NCS-1 and hippocalcin-(1-14) with PtdIns(4,5)P 2 in living cells
Hippocalcin and its N-terminal peptide did not show absolute specificity for the phosphoinositide species in the binding assays, but showed clear preferential binding to PtdIns(4,5)P 2 . This was of high affinity, and since PtdIns(4,5)P 2 is the most abundant of the phosphoinositides in cellular membranes, this suggests that the interaction with PtdIns(4,5)P 2 is likely to be physiologically relevant and contribute to the targeting of hippocalcin and NCS-1. We therefore examined the extent of co-localization of NCS- 1-ECFP with the well characterized PtdIns(4,5)P 2 -specific PH domain of PLCδ1 linked to GFP [25] in living cells. In confocal sections it was clear that, in cells transfected to express only the PLCδ1 PH domain, the majority of the construct was targeted to the plasma membrane ( Figure 6A ). In contrast, in cells coexpressing NCS-1, there appeared to be less of the PH domain construct associated with the plasma membrane; instead it was more cytosolic (Figures 6C and 6D) . To quantify the differences between cells with or without NCS-1-ECFP expression, areas of interest were drawn around the cells and the fluorescence at the cell periphery was determined as a percentage of the total fluorescence for each cell. This assay tends to overestimate the amount of fluorescence that is actually associated with the plasma membrane; nevertheless, a clear reduction in the plasma membrane association of GFP-PLCδ1-PH was observed ( Figure 6K ). It should also be noted that the Golgi localization of NCS-1-ECFP was not seen for the PLCδ1 PH domain. NCS-1 is an activator of phosphatidylinositol 4-kinase IIIβ [29, 30] and interacts with various other target proteins [5] . In order to rule out the possibility that NCS-1 displaced GFP-PLCδ1-PH from the plasma membrane by an indirect mechanism through regulation of a target protein, we also examined the effect on GFP-PLCδ1-PH of co-expression of hippocalcin-(1-14)-ECFP, as this minimal construct would be unlikely to interact with and activate any other proteins. Hippocalcin-(1-14) -ECFP also resulted in displacement of GFP-PLCδ1-PH from the plasma membrane ( Figures 6E, 6F and 6K ). To rule out the possibility that these effects on GFP-PLCδ1-PH localization were due to an increase in expression levels and saturation of binding sites, samples of transfected cells were probed with anti-GFP antibody to detect the expressed proteins. GFP-PLCδ1-PH was expressed at a slightly lower level in co-transfected cells compared with singly transfected cells ( Figure 6L) .
In order to assess the specificity of the effect on GFP-PLCδ1-PH localization, HeLa cells were also transfected to express the PH domain of FAPP1 linked to GFP (Figure 6B ), as this binds preferentially to PtdIns4P and localizes to the Golgi complex [26, 31] . Despite overlapping in localization with both NCS-1-ECFP and hippocalcin-(1-14)-ECFP at the Golgi complex, there was no indication of any dissociation of GFP-FAPP1-PH from the Golgi complex in co-transfected cells, as it remained in a perinuclear localization (Figures 6G-6J ). These data are consistent with high-affinity binding of NCS-1-ECFP or hippocalcin-(1-14)-ECFP to PtdIns(4,5)P 2 rather than to PtdIns4P in live cells.
DISCUSSION
NCS-1 and the closely related protein hippocalcin are targeted to the same cellular membranes (plasma membrane and Golgi complex) through myristoylation. The N-terminal myristoylation motif (residues 1-14) is sufficient to reproduce the targeting of the full-length protein, and this requires the presence of three basic residues at positions 3, 7 and 9 [11, 21] . The N-terminal myristoylation motif of KChIP, which does not possess basic residues at these positions, targets to distinct cellular structures. In order to determine the molecular basis for this specific targeting, we initially used peptides based on the N-terminal sequences, and showed that a myristoylated peptide derived from the Nterminus of hippocalcin is able to bind specifically to the same intracellular structures as NCS-1 and hippocalcin, and binds in vitro with high affinity to phosphoinositides, particularly PtdIns(4,5)P 2 . The peptide did not bind to all acidic phospholipids, and in particular did not bind to phosphatidylserine, which has been shown previously to bind highly basic peptides [32] . The specificity of the lipid interaction was most apparent with a liposome binding assay, which has been shown to be a more reliable indicator of in vivo lipid interactions than the use of immobilized lipids [33] . The specificity for PtdIns(4,5)P 2 among phosphoinositides was not absolute, but the affinity was highest for this lipid, and PtdIns(4,5)P 2 is considerably more abundant than 3-phosphorylated phosphoinositides in cells [34] , suggesting that PtdIns(4,5)P 2 is likely to be the physiologically relevant interaction that could target NCS-1 in resting cells. Studies with the peptides and with the proteins themselves in live cells have shown that their membrane association and binding to PtdIns(4,5)P 2 is dependent on myristoylation [11] .
Myristoylated peptides themselves have very low affinities for lipid bilayers [35] , with K d values of the order of 10 −4 M, suggesting a requirement for other motifs for stable membrane interaction. Certain proteins use a basic region for targeting in addition to myristoylation, but the characteristics of the lipid interactions are distinct from those that we have observed for hippocalcin. The MARCKS (myristoylated alanine-rich C-kinase substrate) protein, for example, has a region with 13 basic residues. Unlike in hippocalcin and NCS-1, these basic residues are situated some distance from the myristoylation motif; also, MARCKS peptides do not show preferential binding to PtdIns(4,5)P 2 over other acidic phospholipids, and in fact bind equally well to liposomes containing phosphatidylserine, suggesting a purely electrostatic interaction [36] . Src also has multiple basic residues close to its myristoylation motif that are required for membrane targeting [37, 38] . It has not been determined whether or not these sequences allow high-affinity interaction with phosphoinositides but, in contrast with the situation with hippocalcin, they do allow high-affinity binding to phosphatidylserine-containing liposomes. The high affinity for PtdIns(4,5)P 2 that we have observed for the myristoylated hippocalcin peptide may arise from the combined effects of insertion of the myristoyl group into the lipid bilayer and interaction of the nearby basic residues with lipid head groups, as suggested from structural studies for recoverin [24] . In particular, the lysine at position 3 is likely to be important, as mutation of this residue disrupts targeting of hippocalcin-(1-14)-EGFP, and this position is not occupied by a basic residue in Src.
The affinity of binding of the N-terminal hippocalcin peptide to PtdIns(4,5)P 2 was high compared with that determined for PH domains that have been classically characterized as PtdIns(4,5)P 2 -binding modules, which have K d values in the micromolar range [27] . In addition to having a lower affinity for PtdIns(4,5)P 2 , the PLCδ1 PH domain that is commonly used as a probe for PtdIns(4,5)P 2 has a high affinity for Ins(1,4,5)P 3 . The PLCδ1 PH domain dissociates from the plasma membrane in response to agonist stimulation [39] , most likely due to its binding to Ins(1,4,5)P 3 rather than as a consequence simply of hydrolysis of PtdIns(4,5)P 2 [39, 40] . In contrast, NCS-1 remains membraneassociated in stimulated cells [11] , and hippocalcin translocates in the reverse direction from the cytosolic compartment to membranes due to its Ca 2+ /myristoyl switch [10, 11] , indicating that these proteins are unlikely to bind Ins(1,4,5)P 3 with high affinity.
The in vitro binding of the N-terminal hippocalcin peptide and in vitro synthesized hippocalcin to PtdIns(4,5)P 2 -containing liposomes was followed up with a demonstration that NCS-1-ECFP and also hippocalcin-(1-14)-ECFP, when co-expressed with GFP-PLCδ1-PH, partially competed this PH domain off the plasma membrane, but had no effect on the localization of the FAPP1 PH domain, which binds preferentially to PtdIns4P. This provides strong support for the idea that these NCS proteins do indeed interact with PtdIns(4,5)P 2 in living cells. GFP-PLCδ1-PH has been widely used as a marker for the localization of PtdIns(4,5)P 2 in live cells. One important issue is that GFP-PLCδ1-PH is associated primarily with the plasma membrane, whereas NCS-1 and hippocalcin are also Golgi complex-associated, although apparent low levels of PtdIns(4,5)P 2 were detectable at the Golgi complex using the PLCδ1-PH probe in ultrastructural studies [41] . Previous work has shown that GFP-PLCδ1-PH is transiently associated with the Golgi complex following cell stimulation [39] . The lack of Golgi localization of GFP-PLCδ1-PH indicates a problem with the use of this construct as a PtdIns(4,5)P 2 probe. PtdIns(4,5)P 2 both is synthesized on and is functionally important for the Golgi complex [42] [43] [44] [45] . Importantly, use of an anti-PtdIns(4,5)P 2 antiserum clearly detected a perinuclear Golgi compartment in fixed cells that was hardly detected in the same cells by GFP-PLCδ1-PH [46] . It has been suggested that PH domains may not report the localization of all lipids to which they could bind due to occupancy by other proteins or to interactions of the PH domain with protein targets that also determines their localization [26, 44, 47] . Recent work has also discovered a PtdIns(4,5)P 2 -independent mode of interaction of PLCδ1-PH with lipid monolayers [48] , which may explain the problems in the use of this PH domain to detect the localization of PtdIns(4,5)P 2 . It is possible, therefore, that the high affinity of the minimal hippocalcin-(1-14) sequence for PtdIns(4,5)P 2 may prove to be a useful additional tool for targeting constructs for the detection of pools of PtdIns(4,5)P 2 in living cells. 
